| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.007 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.008 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.009 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |